Nieuws van Vivetus®
Nieuws van Vivetus®
Pterostilbene Side Effects for Dutch Buyers: 50...
Safety first for Dutch buyers: trials at 50–250 mg/day show mainly mild pterostilbene side effects; monitor LDL and check for drug interactions.
Pterostilbene Side Effects for Dutch Buyers: 50...
Safety first for Dutch buyers: trials at 50–250 mg/day show mainly mild pterostilbene side effects; monitor LDL and check for drug interactions.
8 GMP Checks Buyers Must See Before Ordering Su...
Check eight practical items before buying GMP supplements: certificate scope, batch-specific COAs, supplier traceability, HACCP evidence and contaminant...
8 GMP Checks Buyers Must See Before Ordering Su...
Check eight practical items before buying GMP supplements: certificate scope, batch-specific COAs, supplier traceability, HACCP evidence and contaminant...
Start TMG at 0.5–1 g: Safety and tests for the ...
Safety first TMG advice for the Netherlands. Start at 0.5–1 g, split doses, and monitor homocysteine and lipids. Vivetus® TMG is a tested option.
Start TMG at 0.5–1 g: Safety and tests for the ...
Safety first TMG advice for the Netherlands. Start at 0.5–1 g, split doses, and monitor homocysteine and lipids. Vivetus® TMG is a tested option.
Fisetin bijwerkingen: 200mg safety & drug inter...
A safety-first review of fisetin bijwerkingen: human trial dosing, CYP/transporter interaction risks, and how Vivetus 200mg formulations shape exposure...
Fisetin bijwerkingen: 200mg safety & drug inter...
A safety-first review of fisetin bijwerkingen: human trial dosing, CYP/transporter interaction risks, and how Vivetus 200mg formulations shape exposure...
TMG for NMN Users: Methylation Mechanism and 3–...
Clear explanation of TMG’s methylation and osmolyte roles, why NMN users should care, and practical dosing (0.5–6 g) plus testing steps to guide...
TMG for NMN Users: Methylation Mechanism and 3–...
Clear explanation of TMG’s methylation and osmolyte roles, why NMN users should care, and practical dosing (0.5–6 g) plus testing steps to guide...
8–12 Weeks of Trial Data: Berberine for Adults ...
Berberine modestly improves insulin resistance in adults over 8–12 weeks. Typical trial dose about 1 g/day. Check drug interactions with your clinician first.
8–12 Weeks of Trial Data: Berberine for Adults ...
Berberine modestly improves insulin resistance in adults over 8–12 weeks. Typical trial dose about 1 g/day. Check drug interactions with your clinician first.